40.5% without ED; Pearson’s χ 2 test, p = 0.093), suggesting potential pathway-related differences in staging completeness, although this association did not reach statistical significance in univariable analysis.
← all excerpts
Diagnostic Documentation and Tumour Marker Availability Across Clinical Pathways in Real-World Gastric Cancer.
1
—
—